Cite
MLA Citation
Michael B. Atkins et al.. “Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial.” European journal of cancer, vol. 145, 2021, pp. 1–10. http://access.bl.uk/ark:/81055/vdc_100122905586.0x000032